Dr. Ned R. Warner, D.O.
Gastroenterology (Gastroenterology Physician)
2770 Cortez Ave
Idaho Falls, ID 83404
Who else practices at this address →
Bonneville County includes primary care (1% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of North Texas Hsc, College of Osteopathic Med (2000)
- Years since graduation
- 26
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 357
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2000Medical school: University of North Texas Hsc, College of Osteopathic Med
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
ID license O-0404
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mountain View Hospital Idaho Falls, ID
- Eastern Idaho Regional Medical Center Idaho Falls, ID
- Idaho Falls Community Hospital, LLC Idaho Falls, ID
- Madison Memorial Hospital Rexburg, ID
Medical groups
- Mountain View Hospital LLC (276 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 357
- Services billed
- 784
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 153 | 107 |
| Biopsy of large bowel using a flexible endoscope | 111 | 111 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 106 | 102 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 73 | 72 |
| New patient office or other outpatient visit, 45-59 minutes | 67 | 67 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 31 | 20 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 31 | 30 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 27 | 27 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 19 | 19 |
| Established patient office or other outpatient visit, 20-29 minutes | 16 | 15 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Omeprazole Other prescribers in Idaho Falls, ID | 403 |
| Sod Sulf-Potass Sulf-Mag Sulf (sodium, potassium,mag sulfates) Other prescribers in Idaho Falls, ID | 188 |
| Xifaxan (rifaximin) Other prescribers in Idaho Falls, ID | 68 |
| Dicyclomine Hcl Other prescribers in Idaho Falls, ID | 67 |
| Pantoprazole Sodium Other prescribers in Idaho Falls, ID | 61 |
| Famotidine Other prescribers in Idaho Falls, ID | 45 |
| Furosemide Other prescribers in Idaho Falls, ID | 41 |
| Diphenoxylate-Atropine (diphenoxylate hcl/atropine) Other prescribers in Idaho Falls, ID | 40 |
| Ondansetron Hcl Other prescribers in Idaho Falls, ID | 34 |
| Linzess (linaclotide) Other prescribers in Idaho Falls, ID | 32 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 18 companies reported 59 payments worth $1,040 in total to this clinician.
| AbbVie Inc. | $247 |
|---|---|
| Regeneron Healthcare Solutions, Inc. | $92.03 |
| Takeda Pharmaceuticals U.S.A., Inc. | $78.91 |
| Phathom Pharmaceuticals, Inc. | $78.07 |
| Pfizer Inc. | $75.95 |
| Genzyme Corporation | $69.08 |
| Gilead Sciences, Inc. | $64.00 |
| Aimmune Therapeutics, Inc. | $57.01 |
| Food and Beverage | $1,040 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $19,691 in research payments for these studies, mostly to the institutions running them.
- A Double-blind, Placebo-controlled Phase IIa Study to Evaluate the Efficacy and Safety of AZD7798 in Patients with Moderate to Severe Crohns Disease AMALTHEA
AstraZeneca UK Limited
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.